Vir Biotechnology (VIR) Treasury Shares (2018 - 2019)

Vir Biotechnology has reported Treasury Shares for 8 years, with the latest figure at $5.7 million in Q4 2025.

• Quarterly Treasury Shares rose 14.23% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (up 14.23% YoY) and the FY2025 annual result came in at $5.7 million, up 14.23% from the prior year.
• Treasury Shares rose to $5.7 million in Q4 2025 per VIR's latest filing, from $5.0 million in the prior quarter.
• Over five years, Treasury Shares peaked at $5.7 million in Q4 2025 and troughed at $36298.0 in Q1 2021.
• A 5-year average of $2.9 million and a median of $2.7 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2021 and 2022: Treasury Shares sank 97.51% in 2021, then jumped 7452.44% in 2022.
• Over 5 years, Treasury Shares stood at $1.3 million in 2021, then soared by 109.84% to $2.7 million in 2022, then jumped by 80.11% to $4.8 million in 2023, then advanced by 3.67% to $5.0 million in 2024, then advanced by 14.23% to $5.7 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $5.7 million, $5.0 million, and $4.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.